These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7866217)

  • 1. Clinical pharmacology and therapeutics.
    Breckenridge A
    BMJ; 1995 Feb; 310(6976):377-80. PubMed ID: 7866217
    [No Abstract]   [Full Text] [Related]  

  • 2. Generic Drugs: Expanding Possibilities for Clinical Pharmacology.
    Lionberger R; Uhl K
    Clin Pharmacol Ther; 2019 Feb; 105(2):278-281. PubMed ID: 30703271
    [No Abstract]   [Full Text] [Related]  

  • 3. Criteria for judging proposals for national health care reform with respect to therapeutics.
    Nierenberg DW; Reidenberg MM
    Clin Pharmacol Ther; 1994 Jan; 55(1):1-4. PubMed ID: 8299310
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombolytic therapy for acute myocardial infarction in the 1990s.
    Effron MB; Morales RE
    Md Med J; 1991 Jun; 40(6):485-91. PubMed ID: 1830634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of the specialty drug marketplace for health-system pharmacy: a roundtable discussion.
    Armitstead J; Loyd L; Pane F; Rough S; Shane R
    Am J Health Syst Pharm; 2007 Nov; 64(22):2364-72. PubMed ID: 17989447
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombolytic therapy for coronary occlusion.
    Thompson PL
    Med J Aust; 1992 Jul; 157(2):75-7. PubMed ID: 1630392
    [No Abstract]   [Full Text] [Related]  

  • 7. Developing new drugs for cancer.
    Mead GM; Williams CJ
    BMJ; 1991 Oct; 303(6809):1005-6. PubMed ID: 1805823
    [No Abstract]   [Full Text] [Related]  

  • 8. Health economics. Perfect combination.
    Youle M; Weston R; Trueman P; Swaden L; Leake H
    Health Serv J; 1999 Oct; 109(5675):26-7. PubMed ID: 10662318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maximizing the benefits of thrombolytic therapy for acute myocardial infarction.
    Cairns J; Armstrong PW; Belenkie I; Hirsh J; Johnstone DE; Knudtson M; Lemieux M; Massel D; Naylor CD; Roy L
    CMAJ; 1995 Mar; 152(6):819-22. PubMed ID: 7697574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The extinction of drugs for clinical research: Can the ECNP medicines chest save them?
    Nutt D; Kilpatrick G; Hayes A
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):487-90. PubMed ID: 24508534
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness analysis for multinational clinical trials.
    Pinto EM; Willan AR; O'Brien BJ
    Stat Med; 2005 Jul; 24(13):1965-82. PubMed ID: 15803442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction.
    Krumholz HM; Pasternak RC; Weinstein MC; Friesinger GC; Ridker PM; Tosteson AN; Goldman L
    N Engl J Med; 1992 Jul; 327(1):7-13. PubMed ID: 1598117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Closing the gap.
    Nat Rev Drug Discov; 2006 Feb; 5(2):89. PubMed ID: 16521323
    [No Abstract]   [Full Text] [Related]  

  • 14. The cost-effectiveness of thrombolytic therapy following acute myocardial infarction.
    Fenn P; Gray AM; McGuire A
    Br J Clin Pract; 1991; 45(3):181-4. PubMed ID: 1805915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology. Blue-chip technology.
    Flockhart DA; Webb DJ
    Lancet; 1998 Dec 19-26; 352 Suppl 4():SIV2. PubMed ID: 9872149
    [No Abstract]   [Full Text] [Related]  

  • 16. Economic analysis of the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT-3) study: costs of reperfusion strategies in acute myocardial infarction.
    Kaul P; Armstrong PW; Cowper PA; Eisenstein EL; Granger CB; Van de Werf F; Mark DB
    Am Heart J; 2005 Apr; 149(4):637-44. PubMed ID: 15990746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacoeconomic aspects of treatment of acute myocardial infarction with thrombolytic agents.
    Woo KS; White HD
    Pharmacoeconomics; 1993 Mar; 3(3):192-204. PubMed ID: 10172049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacology in the People's Republic of China.
    Ogilvie RI
    Clin Invest Med; 1986 Nov; 9(4):340-1. PubMed ID: 3802623
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical pharmacology. Roles and responsibilities in academic research.
    Grahame-Smith DG
    Br J Clin Pharmacol; 1991 Aug; 32(2):151-4. PubMed ID: 1931464
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of age on myocardial infarction and thrombolysis.
    Morgan B; Emerman CL
    Am J Emerg Med; 1995 Mar; 13(2):196-8. PubMed ID: 7893308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.